KeyBanc notes that Salesforce (CRM) announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement. The company will leverage Salesforce’s platform, including Agentforce and Data Cloud, to deploy personalized AI agents, supporting operations from medical to commercial and patient support functions. The loss of Takeda to Salesforce follows news late last year of a different Top 20 pharma company choosing to develop a customized solution with Salesforce instead of Vault CRM, the firm notes. Despite this, KeyBanc points out Veeva (VEEV) expects to retain the vast majority of its Veeva CRM customers, and for most of the top 20 pharma companies to decide on whether to migrate to Vault CRM in 2025 & 2026.
Confident Investing Starts Here:
-
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
-
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas" href="https://thefly.com/?utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">Try Now>>
Read More on VEEV:
Latest News
- Novo Nordisk Woes Just Hit Denmark’s Economy. The Stock Is Rising.
- Craig Moffett Believes the Charter-Cox Merger is “Mostly About Wireless”
- The No. 1 Way Americans Become Millionaires Is Pretty Boring — and Easy To Do
- Bernstein Maintains Buy Rating on Nvidia as ‘Jensanity’ Hits Taiwan
- Stock Market Today: Dow Jones Falls, S&P 500 Ends Win Streak; Coffee Kiosks Stock Sinks
- Deutsche Bank Analyst Thinks UnitedHealth Group’s “Issues Are Manageable”
